Company: INV
Filing Date: 2025-04-14
Form Type: 10-K
Source: 0001628280-25-017614
Chunk: 206

Company: Innventure, Inc.
Filing Date: 2025-04-14
Form: 10-K
Item: Item 8
Chunk 206
---
 2, 2024 through December 31, 2024:

105

Table of ContentsInnventure, Inc. and SubsidiariesNotes to Consolidated Financial Statements(in thousands, except share or per share data)

SuccessorOctober 2, 2024 through December 31, 2024Numerator:Net loss attributable to Innventure, Inc. shareholders$(61,754)Less: Cumulative earnings to participating securities217 Undistributed loss for participating securities (61,971)Less: Undistributed loss attributable to participating securities— Net Loss attributable to common shareholders, basic and diluted$(61,971)Denominator:Weighted average number of units outstanding, basic and diluted43,951 Net loss per share attributable to common shareholders, basic and diluted $(1.41)Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential common stock outstanding would have been anti-dilutive.The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock for the periods presented because including them would have been antidilutive:SuccessorDecember 31, 2024Public warrants11,500,000 Private placement warrants7,146,000 WTI warrants1,000,000 Series B preferred shares1,011,869 Share options975,409 RSUs2,036,476 SARs320,000 

Note 18. Related Party TransactionsAs more fully described in Note 5. Borrowings, the Company has various notes with affiliates, including short-term notes with three separate related parties. In addition, the Company had a convertible note to the ESG Fund as part of the 2025 Notes which was converted during the Predecessor period from January 1, 2024 through October 1, 2024.  Transactions with DirectorsAs more fully described in Note 14. Stock-based Compensation, the Company issued various equity awards to related parties throughout 2024. On December 9, 2024, the Company issued 1,246,722 RSUs with a grant date fair value of $15,210, and 590,163 stock options with a grant date fair value of $3,913 to a cumulative of 8 directors. On December 31, 2024, the Company issued 200,000 SARs with a grant date fair value of $7,820 to 4 directors and former directors. On March